Pharmacotherapy of Schizophrenia: Ploypharmacy Approaches
"nSchizophrenia is a debilitating illness, rating as one of the leading causes of lost years of quality of life. The illness imposes a disproportionate burden on patients and their families, healthcare systems and society. Pharmacological management is the cornerstone of treatment of schizo...
Main Authors: | Fatemeh Rahiminejad, Shahin Akhondzadeh |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2010-07-01
|
Series: | Acta Medica Iranica |
Subjects: | |
Online Access: | http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/16188.pdf&manuscript_id=16188 |
Similar Items
-
Pharmacotherapy of Schizophrenia: Ploypharmacy Approaches
by: Fatemeh Rahiminejad, et al.
Published: (2010-08-01) -
The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue.
by: Ralf eBrisch, et al.
Published: (2014-05-01) -
Polypharmacy and relapse of schizophrenia: are they related?
by: R. Softic, et al.
Published: (2022-06-01) -
Delayed onset serotonin syndrome in the setting of polypharmacy
by: Roshan Acharya, et al.
Published: (2021-01-01) -
Polypharmacy Management of Antipsychotics in Patients with Schizophrenia
by: Hiroyuki Kamei
Published: (2022-11-01)